Moderna announces test results for skin cancer vaccine
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Merck
Merck sues government over Medicare drug pricing, claiming "extortion"
Drugmaker says it's unconstitutional for the feds to negotiate drug prices on behalf of seniors. Patient advocates say it's "desperately needed."
Drug companies report progress on potential skin cancer vaccine
Moderna's stock soared after the COVID-19 vaccine maker detailed progress in developing a potential preventive shot for melanoma, a deadly form of skin cancer.
U.S. COVID cases surge ahead of holidays
New cases of the Omicron variant are spreading rapidly in the U.S. ahead of the holidays. People are dealing with long lines at testing sites across the nation. At-home testing kits are also short in supply and pharmacies are limiting how many customers can buy. CBS News correspondent Nancy Chen reports from New York City. Then critical care physician Dr. Lakshmana Swamy joins CBSN's Debra Alfarone to discuss the latest on the pandemic.
FDA approves second COVID treatment pill
The FDA has authorized the second antiviral pill to treat COVID-19. CBS News' Michael George reports. Then Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital at Harvard Medical School, joins CBSN to break down how the drugs work. He also explains why he thinks the CDC should implement "circuit breakers," short-term restrictions on high-risk activities to help curb the spread of the Omicron variant.
Omicron spike collides with holiday travel surge
The FDA authorized the first pill to treat COVID-19. The milestone comes as U.S. cases, hospitalizations and deaths are all rising, with health officials warning of a possible tsunami of new Omicron cases that could overwhelm hospitals. Nancy Chen has the details.
FDA's advisory committee backs Merck's COVID pill
The U.S. may soon be implementing new testing requirements for travelers entering the U.S. amid growing concerns over the new COVID Omicron variant. This week a panel of FDA advisers voted to endorse Merck’s COVID-19 antiviral pill for high-risk individuals. Infectious diseases physician at Brigham and Women's Hospital and chair of that FDA panel, Dr. Lindsey Baden, joins CBSN AM to discuss.
FDA advisers endorse Merck's COVID antiviral drug in narrow vote
The vote paves the way for the agency to authorize molnupiravir for emergency use in American adults.
Pfizer says COVID pill reduces severe illness
Pfizer says its antiviral COVID-19 pill is 89% effective at prevent hospitalizations and 100% effective against deaths from the virus if taken within three days of a person experiencing symptoms. Dr. John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the potentially life-saving drug.
Doctor on COVID antiviral pills and vaccines
Pfizer and Merck have both developed antiviral pills that could help reduce the risk of hospitalization or death from COVID-19. Dr. Giridar Malyah, senior policy officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the latest on the coronavirus pandemic.
COVID antiviral pill approved in the U.K.
A new antiviral drug that is taken orally to treat COVID-19 has been authorized by medical officials in the U.K. The pill from Merck is for people with mild to moderate symptoms or those considered "high risk." CBS News foreign correspondent Imtiaz Tyab joins CBSN anchors Vladimir Duthiers and Anne-Marie Green from London with details.
U.S. COVID-19 infections continue downward trend
Coronavirus infections in the U.S. are declining from their latest peak but experts warn of a possible rough winter ahead. CBS News correspondent Manuel Bojorquez has the day's coronavirus headlines. Then Dr. Andrew Bazemore, a family medicine physician and the senior vice president of research and policy at the American Board of Family Medicine, joins CBSN"s Elaine Quijano to discuss the latest.
Merck seeks FDA authorization for COVID pill
Drugmaker Merck is asking the FDA for an emergency use authorization for an oral pill to treat COVID-19. Manuel Bojorquez reports.
Merck seeks FDA authorization for COVID pill
Merck has asked the FDA for emergency authorization for what would be the first pill to treat COVID-19. CBS News' Skyler Henry reports on the latest. Then Dr. Eric Cioe-Pena, director of global health at Northwell Health, joined CBSN's Tanya Rivero to discuss that plus the timeline on vaccines for kids.
Merck asks FDA to authorize first pill to treat COVID-19
The giant drugmaker is seeking the emergency authorization for molnupiravir, which it says cut hospitalizations and deaths by half among patients with early COVID-19 symptoms.
10/11: CBSN AM
Merck seeks emergency approval for COVID-19 pill; Missing boy in Texas found alive after desperate search
Study: COVID pill cuts deaths in half
Pharmaceutical company Merck says its experimental pill significantly reduces the effects of COVID-19 and plans to submit its findings to the Food and Drug Administration for emergency use authorization. CBS News researcher Max Bayer speaks with CBSN's Tanya Rivero about how this drug differs from those already in use.
Doctor on COVID treatment, rural death toll
Merck says clinical trials show its antiviral pill for COVID-19 can reduce hospitalizations and deaths by half in people recently infected with the virus. Meanwhile, new data shows how hard the virus is hitting rural areas of the U.S. Dr. Ali Mokdad, chief strategy officer for Population Health at the University of Washington, joins CBSN to discuss the latest on the pandemic, plus new research in the medical journal The Lancet about deaths at the hands of police.
New oral COVID treatment shows promising results
A new study shows an oral COVID-19 treatment from Merck reduces the risk of hospitalization and death. CBS News medical contributor, Dr. David Agus joins “CBS Mornings” to discuss.
Merck reports promising results from experimental COVID-19 pill
Company says molnupiravir cut hospitalizations and deaths by half in people recently infected with the virus and it will soon ask authorities to approve the pill's use.
Violence against nurses increases amid pandemic
A new report by National Nurses United finds about 31% of hospital nurses say they have seen an increase in workplace violence. Justin Gill, an urgent care nurse practitioner, health policy lecturer and vice president of the Washington State Nurses Association, joins CBSN to discuss the survey, as well as efforts by Merck to develop an oral antiviral drug to fight COVID-19.
Concerns mount over COVID vaccination rates
The rate of coronavirus vaccinations in the U.S. continues to slow down. This comes as President Biden's goal to get at least 70% of Americans partially vaccinated by July 4 looms. CBS News reporter Alex Tin joins CBSN's "Red & Blue" with the latest updates on the COVID pandemic.
Biden ramps up COVID vaccine production
To help ramp up vaccination efforts, the pharmaceutical company Merck has agreed to help mass-produce Johnson and Johnson's single-dose coronavirus vaccine. President Biden now says there will be enough doses for every adult in the country by the end of May. CBS News correspondent Janet Shamlian reports from Houston, and Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano to discuss the latest.
Health officials monitor COVID mutations
The number of new coronavirus cases and deaths in the United States appear to be leveling off, but health officials are monitoring two highly contagious mutations of the virus that have been circulating throughout the United Kingdom and South Africa. Carl Zimmer, a New York Times columnist, joins CBSN's "Red & Blue" anchor Elaine Quijano with the latest.
Executives announce the OneTen coalition
Executives Ken Frazier of Merck and Ginni Rometty of IBM join "CBS This Morning" to discuss a new coalition, OneTen. The group seeks to train, hire and promote 1 million Black Americans over the next 10 years.
Dow plunges more than 1,600 points as stocks recoil from tariff shock
Nasdaq also sinks more than 1,000 points as investors fret over the potential economic impact of President Trump's latest tariffs.
Top National Security Council staffers purged, U.S. officials say
One source said the firings come after Laura Loomer presented President Trump with opposition research on NSC staffers she views as neoconservatives or not sufficiently loyal to him.
Judge likely to begin contempt proceedings against DOJ over deportation flights
A federal judge said he's likely to begin contempt proceedings against government for failing to answer questions about deportation flights under the Alien Enemies Act.
Pentagon watchdog to evaluate Hegseth's use of Signal
The Pentagon inspector general's office said it would evaluate Hegseth's use of Signal to discuss strikes against the Houthis.
Hailey Okula, nurse influencer, dies from childbirth complications
Hailey Okula, a 33-year-old known online as "Nurse Hailey," died after giving birth to her first child, a son named Crew. She had dealt with infertility for almost two years.
2025 Atlantic hurricane season forecast released
A new forecast from researchers at Colorado State University predicts the 2025 hurricane season will be busier than an average year.
Layoffs spiked by 205% last month, fueled by DOGE mass firings
Job cuts more than tripled to 275,240 last month, a surge caused by mass layoffs of government workers by Elon Musk's DOGE.
Tornadoes and violent winds cause deadly damage in South and Midwest
Tornadoes and violent winds flattened homes and ripped apart buildings from Oklahoma to Indiana.
D.C. top prosecutor nominee touts legal work for Jan. 6 rioters to Senate
D.C. U.S. attorney nominee Ed Martin, in a Senate questionnaire, highlighted his litigation work for two Jan. 6 defendants.
U.S.
More U.S.
Judge likely to begin contempt proceedings against DOJ over deportation flights
A federal judge said he's likely to begin contempt proceedings against government for failing to answer questions about deportation flights under the Alien Enemies Act.
Here's what economists are saying about Trump's "Liberation Day" tariffs
Economists say that President Trump's wide-ranging new tariffs raise the risk of a recession or stagflation.
Lawmakers pursue avenues to counter Trump tariffs
Backlash to President Trump's tariffs cropped up throughout Capitol Hill on Thursday, as Democrats, and some Republicans, expressed concern about the sweeping levies on foreign imports.
Uncertainty for federal workers fired then rehired: "What a mess"
Thousands of probationary employees were rehired by federal agencies after lawsuits challenging the legality of their terminations. But many of them still aren't working.
Ford offers employee pricing to car shoppers as auto tariffs kick in
Ford rolls out employee pricing promotion as new 25% tariffs on U.S. auto imports take effect.
MoneyWatch
More MoneyWatch
Here's what economists are saying about Trump's "Liberation Day" tariffs
Economists say that President Trump's wide-ranging new tariffs raise the risk of a recession or stagflation.
Uncertainty for federal workers fired then rehired: "What a mess"
Thousands of probationary employees were rehired by federal agencies after lawsuits challenging the legality of their terminations. But many of them still aren't working.
Ford offers employee pricing to car shoppers as auto tariffs kick in
Ford rolls out employee pricing promotion as new 25% tariffs on U.S. auto imports take effect.
Stellantis to pause production at Windsor plant, lay off 900 workers in Midwest
Jeep-maker Stellantis is idling production at plants in Canada and Mexico and will temporarily lay off 900 workers in the Midwest.
Trump's tariffs target remote Australian territory inhabited by penguins
The Trump administration hit the remote Australian territory Heard Island and McDonald Islands with a 10% tariff, but no humans inhabit the islands.
Politics
More Politics
Judge likely to begin contempt proceedings against DOJ over deportation flights
A federal judge said he's likely to begin contempt proceedings against government for failing to answer questions about deportation flights under the Alien Enemies Act.
Dr. Oz confirmed to head agency that oversees Medicare and Medicaid
The Senate confirmed Dr. Mehmet Oz is a party line 53-45 vote to lead the Centers for Medicare and Medicaid Services.
Lawmakers pursue avenues to counter Trump tariffs
Backlash to President Trump's tariffs cropped up throughout Capitol Hill on Thursday, as Democrats, and some Republicans, expressed concern about the sweeping levies on foreign imports.
Uncertainty for federal workers fired then rehired: "What a mess"
Thousands of probationary employees were rehired by federal agencies after lawsuits challenging the legality of their terminations. But many of them still aren't working.
Pentagon watchdog to evaluate Hegseth's use of Signal
The Pentagon inspector general's office said it would evaluate Hegseth's use of Signal to discuss strikes against the Houthis.
HealthWatch
More HealthWatch
RFK Jr. cuts CDC labs investigating STD and hepatitis outbreaks
CDC officials are warning of delays and disruptions due to cuts to laboratory staff.
Hailey Okula, nurse influencer, dies from childbirth complications
Hailey Okula, a 33-year-old known online as "Nurse Hailey," died after giving birth to her first child, a son named Crew. She had dealt with infertility for almost two years.
Trump's DEI undoing undermines accommodations for disabled people
From halting diversity programs that benefit disabled workers to federal staffing cuts, the Trump administration has taken a slew of actions that harm people with disabilities.
Here's how cuts at NIH could impact cancer patients
The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.
FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S. health agencies.
World
More World
Trump's tariffs target remote Australian territory inhabited by penguins
The Trump administration hit the remote Australian territory Heard Island and McDonald Islands with a 10% tariff, but no humans inhabit the islands.
New search for MH370 suspended just weeks after it got underway
Malaysia says the latest hunt for missing flight MH370 has been suspended after less than 6 weeks, as "it's not the season" to scour the Indian Ocean.
Rare life-sized statues of toga-clad couple found in Pompeii tomb
The couple may have been married, and the woman appears to have been a priestess, researchers said.
BBC News sneaks in to reveal devastation as Myanmar quake toll tops 3,000
Myanmar's military rulers have kept journalists out since the devastating earthquake, so CBS News' partners at the BBC went undercover to reveal the scale of the disaster.
Stocks slide around the world as investors recoil from Trump tariffs
U.S. financial markets look set to crater in early as trade, with Dow future down nearly 1,300 points.
Entertainment
More Entertainment
Aisha Bowe on her journey from community college to rocket scientist
Aerospace engineer Aisha Bowe opens up about joining the historic all-female Blue Origin space flight.
Bruce Springsteen releasing "Lost Albums" with songs never heard before
Bruce Springsteen announced "Tracks II: The Lost Albums" will feature seven full-length albums that were never released from 1983-2018.
Deborah Norville on leaving "Inside Edition"
Deborah Norville, the longest-serving female anchor in American TV history, says this will be her final season at "Inside Edition." She joins "CBS Mornings" to talk about what's next after three decades on the show.
Tucker Wetmore on debut album
Fresh off his first No. 1 hit and ACM nomination, Tucker Wetmore talks to "CBS Mornings Plus" about his journey to a billion streams and what fans can expect from "What Not To."
Nintendo Switch 2 unveiled
The next generation of Nintendo gaming is here. Tech expert Bridget Carey joins us to break down what to know about the Switch 2 ahead of its June 5 release and why it's already a must-have for Millennials and Gen Z.
Technology
More Technology
Technology
Nintendo unveils new Switch 2 console
Nintendo has unveiled its next console, the Switch 2. Washington Post reporter Gene Park joins "The Daily Report" to discuss the new user experience, the price and possible security concerns.
Amazon tells White House it's interested in buying TikTok
Amazon has expressed interest in buying TikTok ahead of deadline for ByteDance to sell the social media app or face a U.S. ban.
How AI powered robots are helping small farms
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
What to know about RedNote
CBS News Confirmed looks at why users are flocking to RedNote, the new Chinese app raising red flags over data privacy and propaganda, as TikTok faces a potential U.S. ban.
Growing demand to power AI, cryptocurrency
As cryptocurrency and artificial intelligence advancements are made, U.S. demand for the energy needed to power massive mining and data centers grows. David Turk, former deputy secretary of the U.S. Department of Energy, joins "The Daily Report" to discuss how much energy the U.S. needs and the potential environmental impacts.
Science
More Science
Archaeologists discover mass grave from Roman Empire-era battle
Experts at the Vienna Museum provided a public presentation of the mass grave this week, which had the bodies of more than 100 people.
Astronauts on unexpected 9-month space mission
Originally scheduled for just 8 days aboard the International Space Station, the two astronauts spent over 9 months in orbit due to delays with their Boeing Starliner return. Now back on Earth, they share how they coped, what they missed most, and how the mission unexpectedly became political.
Icelandic volcano erupts, shutting down popular tourist attraction
Authorities in Iceland were forced by a new volcanic eruption to evacuate dozens of homes and shut down the hugely popular Blue Lagoon tourist attraction.
SpaceX's Fram2 launch sends civilian crew into flight around Earth's poles
The international all-civilian Fram2 crew is the first in space history to fly to orbit with no licensed pilot or trained astronaut on board.
Ancient wasp snatched prey like Venus flytrap, scientists say
"I've seen a lot of strange insects, but this has to be one of the most peculiar-looking ones I've seen in a while," said one entomologist.
Crime
More Crime
Man wanted for murder breaks leg trying to flee from U.S. Marshals
Charles Ray Blevins, 38, allegedly shot and killed a man while on parole in 2019.
What to know about federal executions as DOJ seeks death penalty for Mangione
Each death penalty case is authorized by the DOJ headquarters in Washington, D.C., in consultation with local U.S. Attorney offices, who prosecute the cases.
Man accused of trying to kill Kavanaugh intends to plead guilty, court docs show
Nicholas Roske was found outside Supreme Court Justice Brett Kavanaugh's home with a gun and a knife in 2022.
Adams reacts to judge dismissing case
New York City Mayor Eric Adams touted a judge's decision to dismiss his federal corruption case with prejudice. Adams faced several counts of bribery, conspiracy and campaign finance violations. CBS News' Shanelle Kaul has more.
Fugitive leader of notorious Ecuador drug gang is indicted in U.S.
José Adolfo Macías Villamar — known as "Fito" — has led Los Choneros and its "network of assassins and drug and weapon traffickers" since at least 2020, federal prosecutors said.
Space
More Space
Aisha Bowe on her journey from community college to rocket scientist
Aerospace engineer Aisha Bowe opens up about joining the historic all-female Blue Origin space flight.
Aisha Bowe prepares for liftoff
Aisha Bowe, a former NASA rocket scientist and tech founder, will become the first person of Bahamian heritage to travel to space. She joins Gayle King and an all-female Blue Origin crew launching April 14 and joins "CBS Mornings' to talk about how she is preparing.
"City-killer" asteroid has slim chance of striking moon, experts say
The 2024 YR4 asteroid has a near-zero chance of striking Earth, but a slim chance of hitting the moon, new research says.
NASA's SPHEREx space telescope releases its first images
The first images captured by NASA's SPHEREx space telescope showed tens of thousands of stars and galaxies.
Wilmore, Williams on space stay
Butch Wilmore and Suni Williams are sharing more details about their experience in space aboard the International Space Station after their time in Boeing's Starliner capsule. CBS News' Mark Strassmann spoke to the pair about their journey.
Latest Galleries
More Latest Galleries
Notable Deaths in 2025
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Husband pieces together wife's last movements to find out how she was killed
A look into a grieving husband Jan Cilliers' investigative work after his wife Christy Giles and her friend Hilda Marcela Cabrales died after a night out.
The Scott Peterson case: New evidence?
Peterson's death sentence for the murder of his pregnant wife Laci has been overturned. Now his supporters are pushing for a complete retrial.
The troubled marriage of Ashley and Doug Benefield
The seesaw marriage between the former ballerina and her much older husband only lasted four years, until she shot him on Sept. 27, 2020.
Texas couple investigates teen daughter's unusual death
Cayley Mandadi's mother and stepfather go to extreme lengths to prove her death was no accident.
Latest CBS News Videos
More Latest CBS News Videos
Latest CBS News Videos
Pentagon watchdog to evaluate Signal leak
The Pentagon's Inspector General's Office said it will look into whether Defense Secretary Pete Hegseth's use of Signal complied with Defense Department policies. CBS News senior national security correspondent Charlie D'Agata reports.
Stocks see biggest wipeout since 2020
Stocks cratered in the U.S. on Thursday, one day after President Trump unveiled his plans for a 10% baseline tariff on all nations and higher levies for some. CBS News' John Dickerson anchors a special report.
Apr 3: CBS News 24/7, 4pm ET
Michigan auto industry braces for Trump's 25% auto tariffs now in effect; Trump's tariffs draw rebukes from world leaders
Trump addresses reporters as markets fall
President Trump spoke to reporters outside the White House Thursday, defending his new trade tariffs despite major market slides. CBS News White House reporter Olivia Rinaldi and CBS News MoneyWatch correspondent Kelly O'Grady have the latest.
Lawmakers react to Trump's tariffs
A resolution to reverse President Trump's tariffs on Canada passed in the Senate as lawmakers grapple with his latest announcement on trade. CBS News' Nikole Killion reports.